Our finding showed for the first time that PLA1A with the highest sensitivity, specificity, and AUC could be used as a single indispensable marker for diagnosis, screening, and prognosis in BRAF-MUT advanced melanoma. The gene discussed is BRAF; the disease is melanoma.